NantHealth’s net loss more than doubled in the third quarter of 2018 as the company struggles to get reimbursed for genetic cancer tests.
NantHealth more than doubles net loss in third quarter
NantHealth’s net loss more than doubled in the third quarter of 2018 as the company struggles to get reimbursed for genetic cancer tests.